Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

ELOS MEDTECH PINOL A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   2.2% 2.2% 2.2% 2.2% 2.2% 2.2% 2.2% 2.2%   Bankruptcy risk   0.3% 2.5% 2.3% 2.2% 0.6% 0.3% 4.3% 4.2%   Credit score (0-100)   100 63 65 65 97 100 48 49   Credit rating   AAA BBB BBB BBB AA AAA BBB BBB   Credit limit (kDKK)   12,282.6 -0.3 -1.6 -2.9 18,606.9 21,309.8 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   87,840 84,821 63,567 106,459 131,699 141,052 0.0 0.0   EBITDA   19,442 20,238 13,211 32,449 44,787 46,357 0.0 0.0   EBIT   19,442 20,238 13,211 32,449 44,787 46,357 0.0 0.0   Pre-tax profit (PTP)   18,851.0 14,958.0 9,579.0 24,834.0 43,262.0 44,383.0 0.0 0.0   Net earnings   14,689.0 14,958.0 9,579.0 24,834.0 34,162.0 34,588.0 0.0 0.0   Pre-tax profit without non-rec. items   18,568 20,238 13,211 32,449 43,406 44,383 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   77,003 0.0 0.0 0.0 91,128 96,615 0.0 0.0   Shareholders equity total   95,731 -110,689 -108,268 -119,102 139,265 162,853 152,504 152,504   Interest-bearing liabilities   23,043 0.0 0.0 0.0 18,944 21,707 0.0 0.0   Balance sheet total (assets)   174,414 181,856 174,005 170,412 208,916 230,061 152,504 152,504   Net Debt   22,754 0.0 0.0 0.0 1,590 20,155 -147,982 -147,982     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   87,840 84,821 63,567 106,459 131,699 141,052 0.0 0.0   Gross profit growth   5.9% -3.4% -25.1% 67.5% 23.7% 7.1% -100.0% 0.0%   Employees   0 171,000 158,000 156,000 174,000 191,000 0 0   Employee growth %   0.0% 0.0% -7.6% -1.3% 11.5% 9.8% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 -98,692.0 -111,651.0 0.0 0.0   Balance sheet total (assets)   174,414 181,856 174,005 170,412 208,916 230,061 152,504 152,504   Balance sheet change%   4.7% 4.3% -4.3% -2.1% 22.6% 10.1% -33.7% 0.0%   Added value   19,442.0 20,238.0 13,211.0 32,449.0 143,479.0 158,008.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   4,309 -86,024 0 0 101,527 8,475 -105,480 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   22.1% 23.9% 20.8% 30.5% 34.0% 32.9% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   11.4% 8.7% 4.6% 11.4% 18.0% 21.5% 0.0% 0.0%   ROI %   13.4% 9.2% 4.6% 11.4% 19.1% 24.7% 0.0% 0.0%   ROE %   16.6% -200.0% -8.7% -21.8% 338.9% 22.9% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   54.9% 0.0% 0.0% 0.0% 64.6% 70.3% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   117.0% 0.0% 0.0% 0.0% 3.6% 43.5% 0.0% 0.0%   Gearing %   24.1% 0.0% 0.0% 0.0% 13.6% 13.3% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   3.1% 0.0% 0.0% 0.0% 14.8% 13.8% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.6 0.0 0.0 0.0 0.7 0.7 0.0 0.0   Current Ratio   2.5 0.0 0.0 0.0 2.2 2.5 0.0 0.0   Cash and cash equivalent   289.0 0.0 0.0 0.0 17,354.0 1,552.0 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   52,320.0 0.0 0.0 0.0 58,578.0 71,376.0 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 1 1 0 0   Employee expenses / employee   0 0 0 0 -1 -1 0 0   EBITDA / employee   0 0 0 0 0 0 0 0   EBIT / employee   0 0 0 0 0 0 0 0   Net earnings / employee   0 0 0 0 0 0 0 0